ARCHIVES

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

Lagging Government Salaries Spur NCI Turnover Among Senior Staff, Threaten Cancer Program

September 5, 1975

NCI-Approved Clinical Trials For The Month of June

June 24, 2011

Bill Would Harm Pancreatic Cancer Research – Scientists Warn Of Unintended Consequences

August 10, 2012

H. Lee Moffitt Cancer Designated A Comprehensive Cancer Center By NCI.

May 4, 2001

Clinical Societies, Patient Groups Need New Alliance, Glick Proposes to ASCO

May 24, 1996

NCI To Recompete NSABP in 1995, Chabner tells Senate

May 20, 1994